Patents by Inventor Javier Fernandez Ruiz

Javier Fernandez Ruiz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944600
    Abstract: The present invention relates to the use of cannabinoids in the treatment of a neurodegenerative disease or disorder. In particular the cannabinoids cannabidiolic acid (CBDA) and cannabidivarin (CBDV) were able to produce neuroprotective effects in a mouse model of neurodegenerative disease. In particular these effects were associated with the symptoms associated with amyotrophic lateral sclerosis (ALS). Furthermore, the combination of the cannabinoid tetrahydrocannabinol (THC) with the drug olexisome provided a synergistic disease modifying effect in a mouse model of neurodegenerative disease. In particular these effects were associated with the symptoms associated with ALS.
    Type: Grant
    Filed: July 10, 2018
    Date of Patent: April 2, 2024
    Assignee: GW Research Limited
    Inventors: Benjamin Whalley, William Hind, Royston Gray, Javier Fernandez-Ruiz, Eva De Lago, Carmen Rodriguez-Cueto, Laura Garcia-Toscano, Irene Santos-Garcia
  • Publication number: 20230024312
    Abstract: The present disclosure relates to the use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease. In particular the cannabinoid is tetrahydrocannabivarin (THCV). Preferably the THCV used is in the form of a botanically derived purified THCV. Alternatively, a synthetically produced THCV is used.
    Type: Application
    Filed: August 25, 2020
    Publication date: January 26, 2023
    Inventors: Benjamin WHALLEY, Javier FERNÁNDEZ-RUIZ, Rosario MORATALLA VILLALBA
  • Publication number: 20210077455
    Abstract: The present invention relates to the use of cannabinoids in the treatment of a neurodegenerative disease or disorder. In particular the cannabinoids cannabidiolic acid (CBDA) and cannabidivarin (CBDV) were able to produce neuroprotective effects in a mouse model of neurodegenerative disease. In particular these effects were associated with the symptoms associated with amyotrophic lateral sclerosis (ALS). Furthermore, the combination of the cannabinoid tetrahydrocannabinol (THC) with the drug olexisome provided a synergistic disease modifying effect in a mouse model of neurodegenerative disease. In particular these effects were associated with the symptoms associated with ALS.
    Type: Application
    Filed: July 10, 2018
    Publication date: March 18, 2021
    Applicant: GW Research Limited
    Inventors: Benjamin Whalley, William Hind, Royston Gray, Javier Fernandez-Ruiz, Eva De Lago, Carmen Rodriguez-Cueto, Laura Garcia-Toscano, Irene Santos-Garcia
  • Publication number: 20070248702
    Abstract: The present invention relates to ligands of the peripheral cannabinoid receptor CB2, especially (+)-?-pinene derivatives, and to pharmaceutical compositions comprising these compounds, and to the use of such compounds for treatment and prevention of the onset of genetic neurodegenerative disorders, in particular Huntington's disease.
    Type: Application
    Filed: December 19, 2006
    Publication date: October 25, 2007
    Inventor: Javier Fernandez-Ruiz
  • Patent number: 6824655
    Abstract: A micro-machining process that includes etching a substrate having copper overlying a dielectric layer to a charged particle beam in the presence of an etch assisting agent. The etch assisting agent is selected from the group consisting of ammonia, acetic acid, thiolacetic acid, and combinations thereof.
    Type: Grant
    Filed: August 26, 2002
    Date of Patent: November 30, 2004
    Assignee: Credence Systems Corporation
    Inventors: Vladimir V. Makarov, Javier Fernandez Ruiz, Tzong-Tsong Miau
  • Publication number: 20030038113
    Abstract: A micro-machining process that includes etching a substrate having copper overlying a dielectric layer to a charged particle beam in the presence of an etch assisting agent. The etch assisting agent is selected from the group consisting of ammonia, acetic acid, thiolacetic acid, and combinations thereof.
    Type: Application
    Filed: August 26, 2002
    Publication date: February 27, 2003
    Inventors: Vladimir V. Makarov, Javier Fernandez Ruiz, Tzong-Tsong Miau